首页 | 本学科首页   官方微博 | 高级检索  
     

2016年哈尔滨市1~19岁健康人群水痘血清流行病学调查
引用本文:李玺琨,高晓丽,李岩,徐虹,范晨璐. 2016年哈尔滨市1~19岁健康人群水痘血清流行病学调查[J]. 中国当代儿科杂志, 2019, 21(3): 203-207. DOI: 10.7499/j.issn.1008-8830.2019.03.003
作者姓名:李玺琨  高晓丽  李岩  徐虹  范晨璐
作者单位:李玺琨, 高晓丽, 李岩, 徐虹, 范晨璐
基金项目:哈尔滨市科学技术局课题(2016RAQYJ192)。
摘    要:目的 了解哈尔滨市1~19岁健康人群水痘IgG抗体水平,为完善水痘防控策略提供理论依据。方法 以随机抽样方法在全市范围内选取1 203名1~19岁健康调查对象,按年龄分为1岁~组(n=240)、4岁~组(n=396)、7岁~组(n=364)和14~19岁组(n=203)。采用酶联免疫吸附试验检测血清中水痘-带状疱疹病毒抗体(VZV-IgG)浓度,VZV-IgG浓度≥ 100 mIU/mL判定为阳性,表明调查对象具有抵抗水痘病毒感染的能力。结果 VZV-IgG的抗体阳性率为71.49%(860/1 203),抗体浓度为447±17 mIU/mL。随着年龄增加,VZV-IgG抗体浓度呈上升趋势(P < 0.05);城市人群抗体阳性率高于农村(P < 0.05);不同剂次水痘疫苗免疫史人群VZV-IgG的抗体阳性率比较差异有统计学意义(P < 0.05),其中以2剂次免疫史人群的抗体阳性率最高。不同病史人群VZV-IgG的抗体浓度比较差异有统计学意义(P < 0.05),其中以患过水痘人群的抗体浓度最高。结论 哈尔滨市1~19岁健康人群水痘抗体水平存在城乡及年龄差异,需加强薄弱地区和14岁以下人群含水痘成分疫苗的接种工作。

关 键 词:水痘  疫苗  抗体浓度  IgG抗体  健康人群  
收稿时间:2019-01-03
修稿时间:2019-02-13

Seroepidemiology of varicella among the healthy population aged 1-19 years in Harbin, China
LI Xi-Kun,GAO Xiao-Li,LI Yan,XU Hong,FAN Chen-Lu. Seroepidemiology of varicella among the healthy population aged 1-19 years in Harbin, China[J]. Chinese journal of contemporary pediatrics, 2019, 21(3): 203-207. DOI: 10.7499/j.issn.1008-8830.2019.03.003
Authors:LI Xi-Kun  GAO Xiao-Li  LI Yan  XU Hong  FAN Chen-Lu
Affiliation:LI Xi-Kun, GAO Xiao-Li, LI Yan, XU Hong, FAN Chen-Lu
Abstract:Objective To investigate the level of IgG antibody to varicella in the healthy population aged 1-19 years in Harbin, China. Methods Random sampling was performed to select 1203 healthy individuals aged 1-19 years in Harbin. According to age, they were divided into ≥ 1 years group (n=240), ≥ 4 years group (n=396), ≥ 7 years group (n=364) and 14-19 years group (n=203). Enzyme-linked immunosorbent assay was used to measure the concentration of varicella-zoster virus (VZV)-IgG antibody in serum, and a concentration of VZV-IgG antibody of ≥ 100 mIU/mL was considered positive, suggesting that the subject had the ability to resist VZV infection. Results The overall positive rate of VZV-IgG antibody was 71.49% (860/1203), and the concentration of VZV-IgG antibody was 447±17 mIU/mL. The concentration of VZV-IgG antibody tended to increase with age (P < 0.05). The positive rate of VZV-IgG antibody in the urban population was significantly higher than that in the rural population (P < 0.05). There was significant difference in the positive rate of VZV-IgG antibody between the populations with different doses of varicella vaccination (P < 0.05), and the population with 2 doses of vaccination had the highest positive rate of VZV-IgG antibody. There was a signifcant difference in the concentration of VZV-IgG antibody between the populations with different medical histories (P < 0.05), and the population with a past history of varicella had the highest concentration. Conclusions Among the healthy population aged 1-19 years in Harbin, there is a signifcant difference in the level of VZV-IgG antibody between the urban and rural populations, as well as between different age groups. Varicella vaccination should be strengthened in areas with a low vaccination rate and the population aged <14 years.
Keywords:

Varicella|Vaccine|Antibody concentration|IgG antibody|Healthy population

点击此处可从《中国当代儿科杂志》浏览原始摘要信息
点击此处可从《中国当代儿科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号